Table 4

The effect of AG treatment on LPS-stimulated decrease in microsomal P450 hydroxylase activities

TimeSalineLPSLPS + AGAG
hr nmol/mg/min
Testosterone hydroxylation
 6β61.15  ± 0.030.85  ± 0.044-150 1.23  ± 0.061.49  ± 0.26
241.52  ± 0.170.76  ± 0.134-150 0.29  ± 0.124-150 0.71  ± 0.094-150
 7α60.65  ± 0.010.58  ± 0.060.54  ± 0.150.48  ± 0.10
240.55  ± 0.090.13  ± 0.034-150 0.22  ± 0.034-150 0.40  ± 0.06
 15α60.40  ± 0.050.22  ± 0.070.28  ± 0.080.36  ± 0.09
240.36  ± 0.080.22  ± 0.014-150 0.12  ± 0.034-150 0.19  ± 0.024-150
 16α60.60  ± 0.030.44  ± 0.070.47  ± 0.070.52  ± 0.12
240.19  ± 0.060.04  ± 0.014-150 0.19  ± 0.050.18  ± 0.07
 16β60.89  ± 0.090.84  ± 0.060.59  ± 0.060.40  ± 0.124-150
240.82  ± 0.060.49  ± 0.024-150 0.14  ± 0.024-150 0.12  ± 0.014-150
p-Nitrophenol hydroxylation
61.51  ± 0.051.16  ± 0.124-150 0.75  ± 0.114-150 0.91  ± 0.044-150
241.36  ± 0.240.65  ± 0.074-150 0.98  ± 0.131.21  ± 0.12

Mice were injected with LPS followed by repeated injections of AG every 4 hr for 6 and 24 hr. Animals were killed at the appropriate times and hepatic microsomal protein isolated and analyzed as described in Materials and Methods. The data presented in the table represent the mean ± standard error of five mice per treatment group.

    • 4-150  Significantly different from control, p < 0.05.